Best Penny Stocks To Consider – October 29th

Cambium Networks, Purple Biotech, Beyond Meat, Ernexa Therapeutics, and fuboTV are the five Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are shares of very small companies that trade at very low prices—commonly under $5 per share in the U.S. (and often used colloquially to refer to sub-$1 issues)—and are frequently quoted on over‑the‑counter markets or small exchanges. They typically have low liquidity, wide bid‑ask spreads, limited public information, and high volatility, making them highly speculative and risky for investors. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Cambium Networks (CMBM)

Cambium Networks Corporation, together with its subsidiaries, engages in the design, development, and manufacture of wireless broadband and Wi-Fi networking infrastructure solutions. The company offers point-to-point fixed wireless backhaul and point-to-multipoint fixed wireless solutions; and enterprise solutions comprising cnMatrix cloud-managed wireless-aware switching solution, Xirrus Wi-Fi solutions, and Wi-Fi 6/6E access points which support cnMaestro and Xirrus XMS management.

Read Our Latest Research Report on CMBM

Purple Biotech (PPBT)

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage.

Read Our Latest Research Report on PPBT

Beyond Meat (BYND)

Beyond Meat, Inc., a plant-based meat company, develops, manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club stores, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools.

Read Our Latest Research Report on BYND

Ernexa Therapeutics (ERNA)

Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited.

Read Our Latest Research Report on ERNA

fuboTV (FUBO)

Read Our Latest Research Report on FUBO

Recommended Stories